When the coronavirus outbreak broke out, there was a debate about whether people should be allowed to go abroad on a vaccine basis.
The WHO World Health Organization prepares a list of vaccines. Discussions are currently underway to allow the public to be vaccinated on a future basis, with the protocol that travel can be undertaken if the test result is negative.
The central government has said the matter is under discussion at the World Health Organization, but no final decision has been made.
Vaccines approved by WHO.
So far only test guidelines have been published. The guidelines issued so far are for testing only, i.e., the corona infection should be negative before the test trip.
There is currently no consensus in the World Health Organization on the issue of vaccination, but the debate is still ongoing, said Lav Agarwal, Joint Secretary of the Ministry of Health.
is covaxin approved by WHO.
The WHO prepares a list of vaccines that will be included in the Emergency Use List (EUL).
Those vaccines will be added to the list, and those who are vaccinated are eligible to travel to other countries so that they do not have to undergo repeated corona testing.
In the list that the World Health Organization has created so far, there is a name for AstraZeneca, but not covaxin.
The AstraZeneca vaccine is manufactured in India by a serum company called Covishield. If the name of the COVAXIN vaccine is not included in the final list, the overseas travel of millions of vaccinated people in India may be questionable.
Lav Agarwal, Joint Secretary, Ministry of Health, said the RTPCR negative report was the basis of the visit.
The World Health Organization has not yet commented on the vaccine passport.
It is noteworthy that China also introduced the corona vaccine sinopharm in December last year and has been exporting to many countries.
But it was approved by the World Health Organization on May 9.
Similarly, the application for covaxin accreditation is pending with the World Health Organization, which can decide at any time.
covaxin and international travel controversy.
In fact, according to a report, other countries may refuse to issue visas to covaxin takers due to lack of WHO accreditation.
Javadekar said such reports are coming in when the World Health Organization has not made any decision to link the vaccine to foreign trips.
He said it was not right to raise such a controversy. covaxin is very effective. Initially, Congress leaders raised this question, and as a result, many are still reluctant to get vaccinated.
It is noteworthy that a prestigious scientific journal such as Lancet described covaxin as safe and effective against the coronavirus. All research has found evidence of efficacy in all types of the corona, and this has been confirmed by Dr. Anthony Fossie, , Chief Medical Adviser to the President of the United States.